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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYHematopoietic stem cells (HSCs) inhabit distinctmicroenvironments within the adult bonemarrow (BM), which govern the delicate bal-
ance between HSC quiescence, self-renewal, and differentiation. Previous reports have proposed that HSCs localize to the vascular niche,
comprised of endothelium and tightly associated perivascular cells. Herein, we examine the capacity of BM endothelial cells (BMECs) to
support ex vivo and in vivo hematopoiesis.We demonstrate that AKT1-activated BMECs (BMEC-Akt1) have a unique transcription factor/
cytokine profile that supports functional HSCs in lieu of complex serum and cytokine supplementation. Additionally, transplantation of
BMEC-Akt1 cells enhanced regenerative hematopoiesis following myeloablative irradiation. These data demonstrate that BMEC-Akt1
cultures can be used as a platform for the discovery of pro-HSC factors and justify the utility of BMECs as a cellular therapy. This technical
advance may lead to the development of therapies designed to decrease pancytopenias associated with myeloablative regimens used to
treat a wide array of disease states.INTRODUCTION
The adult bone marrow (BM) is composed of distinct
microenvironments that maintain hematopoietic stem
cell (HSC) homeostasis by modulating self-renewal and
differentiation (Morrison and Scadden, 2014). HSCs are
located adjacent to the vascular niche, composed of endo-
thelial cells (ECs) and stromal perivascular cells (Kiel et al.,
2005; Kunisaki et al., 2013). ECs and LEPR+ mesenchymal
stem cells (MSCs) have emerged as primary components
of the BM-HSC niche, producing many of the pro-hemato-
poietic factors needed for HSC homeostasis (Kobayashi
et al., 2010; Morrison and Spradling, 2008; Sauvageau
et al., 2004). The endothelial and LEPR+ cell-derived
cytokines, stem cell factor (KITL) and CXCL12 (SDF1a),
are required for the maintenance of the HSC pool
(Ding and Morrison, 2013; Ding et al., 2012; Greenbaum
et al., 2013). Our group has demonstrated that loss of
JAGGED-1 in ECs leads to the premature exhaustion of
NOTCH-dependent HSCs (Butler et al., 2010; Poulos
et al., 2013). Despite our refined understanding of the
architectural and functional communication between the
vascular niche and HSCs, the regulatory mechanisms gov-
erning these interactions have not been fully elucidated.
Tissue-specific ECs possess distinct gene expression sig-
natures and functional heterogeneity, suggesting that tis-Stem Cell Rsue-specific ECs maintain their resident stem cells during
homeostasis and regeneration (Nolan et al., 2013). Within
the BM microenvironment, perivascular cells found in
close association with ECs form an HSC niche, regulating
long-term HSC maintenance and quiescence (Kunisaki
et al., 2013; Zhou et al., 2014). However, the development
of a method to test the ability of niche-specific BM endo-
thelial cells (BMECs) to support repopulating HSCs has
been lacking. Moreover, the inability to isolate and culti-
vate stable, long-lasting, organ-specific murine ECs has
limited the field of vascular biology, especially in studies
that attempt to define the role of ECs in HSCmaintenance.
Even when one is able to establish an endothelial culture,
the need for chronic supplementation with serum and
endothelial-specific growth factors leads to the differentia-
tion of HSCs during co-culture. Current EC isolation proto-
cols result in the cultivation of heterogeneous populations
of niche cells, including stromal cells that can rapidly
outcompete ECs in long-term cultures.
We have previously demonstrated that AKT1-activated
primary human ECs isolated from umbilical vein can
expand bona fide mouse HSCs (Butler et al., 2010). In this
study, we describe a protocol for the reproducible isolation
and culture of AKT1-activated murine BMECs (BMEC-
Akt1). Our approach enables the survival of BMEC-Akt1
cultures while maintaining their specific angiogenic andeports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 The Authors 881
angiocrine growth factor profiles, withoutmalignant trans-
formation. We have developed a co-culture assay that re-
veals a dynamic BMEC-Akt1 transcriptional landscape,
leading to changes in the BMEC-Akt1 transcription factor
and cytokine/growth factor profile in response to hemato-
poietic cross-talk. BMEC-Akt1 cultures are endowed with
the instructive capacity to support long-term repopulating
HSCs ex vivo in the absence of complicating exogenous
serum and cytokine cocktails. Moreover, the transplanta-
tion of niche-specific BMEC-Akt1 cells following an LD50
dose of radiation in mice leads to absolute survival and
enhances hematopoietic recovery in the absence of a life-
saving BM transplant. These mitigating effects were partly
achieved by minimizing the duration of pancytopenia and
organ damage associated with myeloablative treatment.
The establishment of our BMEC-Akt1 cultures will allow
us to begin to dissect the complex cellular network of the
BM vascular niche by enabling the discrete interrogation
of BMEC-HSC interactions, providing a platform to further
our understanding of the necessary microenvironmental
signals that dictate HSC homeostasis, allowing for the
development of tailor-made ex vivo and in vivo therapies
for hematological disorders.RESULTS
Isolation and Characterization of BM Vascular Niche
Cells
Using a Vegfr3::YFP reporter mouse (Calvo et al., 2011)
(Figure 1A), we confirmed that the BM vasculature is com-
posed of two distinct VECAD+ EC populations, including
SCA1+VEGFR3 arteriole and SCA1VEGFR3+ sinusoid
ECs (Hooper et al., 2009). To test whether the endothelial
and perivascular components of the BM vascular niche
support adult HSCs ex vivo, we sought to establish highly
pure and robust BMEC and BM stromal (BMS) cultures.
Long bones isolated from adult C57BL/6J mice were enzy-
matically digested and depleted of lineage+ hematopoietic
cells, followed by a CD31+ cell enrichment. CD31+ and
CD31 cell suspensions were plated on fibronectin-coated
wells and transduced with a constitutively active Akt1-ex-
pressing lentivirus, allowing for the outgrowth of primary
CD31+ BMECs (BMEC-Akt1) and CD31 BMS (BMS-Akt1)
(Figure 1A). Resulting cultures expressed genes character-
istic of endothelial and stromal cells (Figures S1A and
S1B). To confirm the identity of our BMEC-Akt1 cultures,
we analyzed the expression of pan EC (VECAD), arteriole
EC (SCA1), and sinusoidal EC (VEGFR3) markers (Hooper
et al., 2009). BM-derived ECs displayed a phenotypic
arteriole identity, staining for SCA1, but not VEGFR3
(Figure 1B). To test the ability of our BMEC-Akt1 cultures
to undergo in vivo tubulogenesis, matrigel plugs contain-882 Stem Cell Reports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 Theing mCherry-labeled BMEC-Akt1 and mCerulean-labeled
BMS-Akt1 cells were implanted subcutaneously into
C57BL/6J mice and assayed for vessel formation and
anastomosis. Matrigel plugs revealed co-localization of
mCherry+ cells with an Isolectin-B4 intravital vascular label
(Figure 1C), while BMS-Akt1 controls were found within
the interstitial parenchymal space. BMS-Akt1 cells ex-
pressed PDGFRA, LEPR, and PRX1 (Figure 1D), suggesting
that our stromal cultures contain LEPR+ perivascular niche
cells that contribute to the maintenance of HSCs in vivo
(Ding and Morrison, 2013; Ding et al., 2012). Given that
LEPR+ stromal cells possess features of MSCs (Zhou et al.,
2014), we analyzed the potential of our isolated stromal
cells to differentiate into MSC lineages. BMS-Akt1 cells
were able to form osteoblasts, chondrocytes, and adipo-
cytes in in vitro differentiation assays, staining positively
for Alizarin Red S (osteoblast), Oil Red O (adipocyte), and
Toluidine Blue O (chondrocyte) (Figure 1E). Differentiated
BMS-Akt1 cells also upregulated tissue-specific transcripts,
including Bglap, Omd (osteoblast), Fasn, Acly (adipocyte),
Acan, Hapln1 (chondrocyte) (Figure S1C).
Whole-transcriptome profiling (RNA sequencing) of
BMEC-Akt1 and BMS-Akt1 cultures confirmed enrichment
of arteriole EC and canonicalMSC-related genes (Figures 2A
and 2B). BMEC-Akt1 and BMS-Akt1 cells were also enriched
for pro-hematopoietic growth factors (Figures 2A and 2B)
expressed in the in vivo BM endothelial and stromalmicro-
environment (Figure S2). Gene ontology (GO) analysis
demonstrated that differentially expressed genes in
BMEC-Akt1, compared with BMS-Akt1, were associated
with blood vessel development, while differentially ex-
pressed genes in BMS-Akt1 cells were enriched for processes
that maintain the structure and function of tissues (Figures
2C and 2D). Taken together, we have isolated robust, long-
term BMEC-Akt1 and BMS-Akt1 cultures that maintain
their functional capacities. Isolated BMEC-Akt1 and BMS-
Akt1 cells demonstrated the ability to be cultured for at least
14 days without serum or exogenous cytokines (data not
shown);wenext sought to examine the instructive capacity
of BMEC-Akt1 and BMS-Akt1 cells in serum- and cytokine-
free hematopoietic stem and progenitor cell (HSPC) co-cul-
tures to support long-term repopulating HSCs.
BMEC-Akt1 Supports the Ex Vivo Culture of
Repopulating HSCs
To examine the capacity of our BMEC-Akt1 and BMS-Akt1
cells to support HSCs, we developed an ex vivo co-culture
system in which CD45+lineagecKIT+SCA1+ (LKS) HSPCs
were cultured on a feeder layer of BMEC-Akt1 or BMS-
Akt1 cells under serum-free conditions. Adult C57BL/6J
(CD45.2+) HSPCs were sorted to purity and plated (2,500
LKS cells) on a confluent well of BMEC-Akt1 or BMS-Akt1
cells in StemSpan Serum-Free media supplemented withAuthors
Figure 1. Generation of BM-Derived Endothelial and Stromal Cells
(A) Schematic of BMEC and BMS cell isolations. VECAD+SCA1+VEGFR3 arteriole (white arrowhead) and VECAD+SCA1VEGFR3+ sinusoidal
(red arrowhead) BMECs in vivo (scale bar represents 100 and 50 mm). Phase-contrast images of isolated BMEC-Akt1 and BMS-Akt1 cultures
(scale bar represents 200 mm).
(B and C) BMEC-Akt1 cultures demonstrate VECAD+SCA1+VEGFR3 arteriole staining (B) (scale bar represents 50 mm) and produce vessels
in vivo (C). BMEC-Akt1 (red), but not BMS-Akt1 (blue), co-localize with intravitally labeled vasculature (Isolectin-B4; green) in matrigel
plugs (scale bar represents 25 mm).
(D and E) BMS-Akt1 cultures display PDGFRA+PRX1+LEPR+ BMS staining (D) (scale bar represents 50 mm) and give rise to osteogenic
(Alizarin Red S), adipogenic (Oil Red O), and chondrogenic (Toluidine Blue O) progeny in vitro (E) (scale bar represents 200 mm).50-ng/ml soluble KITL (sKITL). No feeder cultures served as
controls (Figures 3A and 3B). Hematopoietic cells were as-
sayed following 9 days of co-culture. While BMEC-Akt1
and BMS-Akt1 promoted the expansion of total CD45+
cells, only BMEC-Akt1 supported the expansion of phe-
notypic HSPCs (greater than >14-fold), with no feeder
and BMS-Akt1 conditions unable to maintain input levels
of phenotypic LKS cells (Figures 3C and S3). Lineage+ cells
were primarily phenotypic GR1+/CD11B+ myeloid for
all co-culture conditions (data not shown). To quantify pro-
genitor activity, total CD45+ cells were sorted from BMEC-Stem Cell RAkt1 and BMS-Akt1 co-cultures, plated in methylcellulose,
and scored for colony-forming units (CFUs). All conditions
maintained appreciable levels of progenitor activity, while
BMEC-Akt1 co-cultured CD45+ cells possessed significantly
higher levels of CFU-E and CFU-G activity (Figures 3D and
3E). To assess the long-term, multi-lineage engraftment ca-
pacity of our ex vivo co-cultured HSPCs, 105 total CD45.2+
sorted cells were transplanted into lethally irradiated (950
Rads) CD45.1+ recipients with 5 3 105 CD45.1+ whole
BM (WBM) cells as a competitive dose. BMEC-Akt1 co-
cultured CD45+ cells show stable engraftment in recipienteports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 The Authors 883
Figure 2. BMEC-Akt1 and BMS-Akt1 Cells Express Pro-hematopoietic Factors and Are Enriched in Pathways Involved in Vascular and
Organ Development
(A) Heatmaps of relative gene expression from three independently derived BMEC-Akt1 and BMS-Akt1 lines.
(B) BMEC-Akt1 and BMS-Akt1 cultures demonstrate enrichment in endothelial and MSC gene expression, respectively. BMEC-Akt1 and BMS-
Akt1 cultures show enrichment for pro-hematopoietic factors. Error bars represent mean ± SEM and significance was determined by
Student’s t test; *p < 0.05, **p < 0.01, ***p < 0.001. Three independently isolated BMEC-Akt1 and BMS-Akt1 lines were analyzed.
(C and D) BMEC-Akt1 lines are enriched in angiogenic and vascular development pathways. GO analysis of differentially expressed genes in
BMEC-Akt1 and BMS-Akt1 cell lines reveals the enrichment of distinct pathways (log10 p value = red line; number of genes enriched in
target pathway = bar graph).mice (Figures 3D and 3F), with BMS-Akt1 and feeder-free
controls producing diminutive levels of CD45.2+ cells in
the peripheral blood. BMEC-Akt1 co-cultured CD45.2+
cells were capable of multilineage engraftment at 16 weeks
(Figure 3G), while BMS-Akt1 and no feeder CD45.2+ con-
trols did not make significant contributions to any lineage
(data not shown). To test the self-renewal capability of the
BMEC-Akt1 co-cultured CD45.2+ HSCs and eliminate the
possibility that co-cultures enriched for progenitor activity
promoted primary hematopoietic engraftment, we per-
formed secondary transplantations and found an increase
in the percentage of engrafted CD45.2+ cells at 16-weeks
post-transplant with multilineage potential (Figure 3H).884 Stem Cell Reports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 TheThese data suggest that BMEC-Akt1 acts as an ex vivo
pro-HSC niche that provides the appropriate combination
and levels of angiocrine factors that regulate the mainte-
nance of HSCs, retaining their ability to repopulate lethally
irradiated recipients, leading to long-term, multilineage
engraftment.
BMEC-Akt1 Co-cultures Support HSCs without
Exogenous KITL
Genetic evidence indicates that the deletion of Kitl in ECs
results in a significant decrease in overall HSC numbers
and function in the BM (Ding et al., 2012). To test whether
cultured BMEC-Akt1 express physiological levels of KITLAuthors
Figure 3. BMEC-Akt1 Cultures Support
HSPCsunder Serum-FreeConditions ExVivo
(A) Schematic of ex vivo co-culture assay.
HSPCs were co-cultured for 9 days with
50-ng/ml sKITL in serum-free media.
(B) Phase-contrast images of day 9 HSPC co-
cultures (scale bar represents 200 mm).
(C) BMEC-Akt1 cells support HSPC mainte-
nance ex vivo. Quantification of total CD45+
hematopoietic cells and LKS HSPCs following
9 days of co-culture. Fold expansion is
defined as total LKS (day 9)/input LKS
(day 0).
(D) Schematic of functional assays. Day 9
co-cultured CD45.2+ cells were purified from
feeders and plated in methylcellulose and
scored for CFUs or transplanted into lethally
irradiated CD45.1+ recipients with a CD45.1+
WBM competitive dose.
(E) BMEC-Akt1 co-cultures maintain multi-
lineage hematopoietic progenitor activity
ex vivo.
(F and G) HSPCs cultured on BMEC-Akt1 cells
engraft lethally irradiated recipients (F) and
demonstrate multilineage potential 16 weeks
post-transplant (G).
(H) BMEC-Akt1 cultured HSCs engraft sec-
ondary recipients (dashed red line) and
maintain multilineage potential. n = 10
mice per condition. Error bars represent
mean± SEM and significance was determined
by Student’s t test; *p < 0.05, **p < 0.01,
***p < 0.001.that support the maintenance of repopulating HSPCs
ex vivo, we co-cultured HSPCs on BMEC-Akt1 in the
absence of exogenous sKITL. Omitting sKITL resulted in a
significant decrease in total hematopoietic cells and HSPC
fold expansion (Figures 4A and 4B). However, even in the
absence of exogenous sKITL, BMEC-Akt1 cultures were still
able to expand phenotypic LKS HSPCs by 3.5-fold (Fig-
ure 4A). Total CD45+ cells co-cultured in the presence or
absence of exogenous sKITL displayed no differences in
progenitor activity (Figure 4C). To assess long-term engraft-
ment, 105 CD45.2+ co-cultured cells and 5 3 105 CD45.1+
competitor WBM cells were transplanted into lethally irra-
diated CD45.1+ recipients. BMEC-Akt1 co-cultured HSPCs
without sKITL (Figure 4D; black box, solid line) were able
to produce long-term engraftment, albeit at a significantly
lower proportion than cultures supplemented with sKITL
(Figure 4D; red circle, solid line). To confirm that BMEC-
Akt1 cultures were supporting long-term repopulating
HSCs, we transplanted 1000 CD45.2+ LKS cells from co-cul-Stem Cell Rtures without sKITL with 53 105 short-term CD45.1+ Sca1-
depleted WBM into lethally irradiated CD45.1+ mice.
CD45.2+ HSPCs cultured on BMEC-Akt1 in the absence of
sKITL resulted in long-term engraftment that stabilized at
>90% by 16-weeks post-transplant (Figure 4D; black box,
dashed line), with myeloid and lymphoid contributions
similar to non-competitive transplantations (Figure 4E).
These data suggest that BMEC-Akt1 provides sufficient an-
giocrine signals to promote the maintenance of bona fide
HSCs ex vivo.
HSPC Co-culture Modulates BMEC-Akt1 Gene
Expression
In the BM microenvironment, HSCs are found in close
proximity to the vasculature (Kiel et al., 2005; Kunisaki
et al., 2013), suggesting that direct cellular contact may
be necessary for the maintenance of resident stem cells.
However, little is known about the cross-talk between
HSCs and cells that composes the supportive environment.eports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 The Authors 885
Figure 4. BMEC-Akt1 Support HSPCs Ex Vivo in the Absence of Exogenous Cytokines
(A) BMEC-Akt1 cells without sKITL maintain HSPCs ex vivo. Quantification of total CD45+ hematopoietic cells and LKS HSPCs following
9 days of co-culture in serum-free conditions. Fold expansion is defined as total LKS (day 9)/input LKS (day 0).
(B) Representative contour plots of expanded LKS cells. Plots are gated on lineage populations (not shown). Frequency of cKIT+SCA1+
populations (red box) are expressed as a percentage of total lineage cells.
(C) sKITL is not required to maintain multi-lineage hematopoietic progenitor activity. CFUs were assayed from total CD45+ cells following
co-culture.
(D) BMEC-Akt1 maintain long-term repopulating HSCs in the absence of serum and exogenous cytokines. Total CD45.2+ cells co-cultured on
BMEC-Akt1sKITL (red circle, solid line) or +sKITL (black square, solid line) were transplanted with a standard CD45.1+ WBM rescue dose.
Purified LKS cells from BMEC-Akt1 HSPC co-cultures-sKITL (black box, dashed line) were transplanted with a CD45.1+ SCA1-depleted WBM
rescue dose. Engraftment was monitored by %CD45.2+ contribution to the peripheral blood.
(E) BMEC-Akt1 +sKITL (red), BMEC-Akt1 -sKITL (black), and BMEC-Akt1 -sKITL with Sca1-depleted rescue dose (white) co-cultures
demonstrated multilineage engraftment at 16-weeks post-transplant. n = 10 mice per condition. Error bars represent mean ± SEM, and
significance was determined by Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001, n.s., not significant.To explore this reciprocal cross-talk, we co-cultured BMEC-
Akt1 and BMS-Akt1 with HSPCs (Figure 3A), sorted
(CD45DAPI) to collect purified feeders (Figure S4), and
analyzed via RNA sequencing. Feeders grown in co-culture
media without HSPCs were used as baseline controls.
Principal component analysis (PCA) and hierarchical clus-
tering of RNA-sequencing data from cultured BMEC-Akt1
and BMS-Akt1 cells alone or following co-culture demon-
strated a strong segregation into four distinct groups, ac-
counting for 90% of the variance in the dataset (Figures
5A and S4B). Pairwise comparisons of BMEC-Akt1 ±HSPCs
and BMS-Akt1 ± HSPCs co-cultured feeders yielded 184
and 270 differentially expressed genes, respectively (Fig-
ures 5B–5D). The distribution and significance of gene
expression is visualized by comparing the log2 fold change
with the log10 p value and by scaling the log2 FPKM
values by row in a heatmap (Figures 5C and 5D). Analysis
of pro-hematopoietic factors revealed a similar pattern of
expression for most genes in the individual cell type and886 Stem Cell Reports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 Theco-cultures (Figure 5E). Nine differentially expressed tran-
scription factors were observed in BMEC-Akt1, four of
which were upregulated (Myb, Nfe2, Sox9, and Vdr) and
five of which were downregulated (Egr3, Esr1, Fosb, Id4,
and Tox2) in the presence of HSPCs (Figure 5F, left). Twelve
transcription factors were differentially expressed in the
BMS-Akt1 cells, ten of which were upregulated (Atf3,
Bhlhe40, Fosb, Jun, Junb, Jund, Klf2, Klf4, Maff, and Nfil3)
and two of which were downregulated (Lhx6 and Nr4a2)
following co-culture (Figure 5F, right). Fosb was common
between these two lists; however, it was differentially regu-
lated between BMEC-Akt1 and BMS-Akt1 in the presence of
HSPCs. Nine and seven differentially expressed cytokines
were identified in BMEC-Akt1 and BMS-Akt1 cell lines,
respectively (Figure 5G); BMEC-Akt1 co-cultures upregu-
lated the expression of eight genes (Ccl7, Ccl9, Ccr2, Lrg1,
Pf4, Pglyrp1, Ppbp, and Tnfrsf9) and downregulated the
expression of one gene (Cx3cl1) and BMS-Akt1 co-cultures
upregulated the expression of three genes (Gpi1, Itgb3, andAuthors
Figure 5. HSPCs Modulate Gene Expression Changes in BMEC-Akt1 and BMS-Akt1 Cells
(A) PCA of BMEC-Akt1 and BMS-Akt1 cell lines alone and in co-culture with HSPCs.
(B) Venn diagram of differentially expressed (absolute log2 fold change > 2, p value < 0.05, and expression >10 FPKM) genes in the BMEC-
Akt1 ± HSPC and BMS-Akt1 ± co-culture comparisons.
(C and D) Distributions of gene expression were visualized by volcano plots of the log2 fold change and log10 p values and heatmaps of
BMEC-Akt1 and BMS-Akt1 cells alone or following HSPC co-culture. Differentially expressed genes (absolute log2 fold change > 2, p value <
0.05) are marked as black and green for BMEC-Akt1 and BMS-Akt1, respectively. Representative conserved gene expression changes are
noted.
(E) Heatmaps of known pro-hematopoietic factors following HSPC co-culture.
(F and G) Differentially expressed transcription factors (F) and chemokines and cytokines identified in BMEC-Akt1 and BMS-Akt1 cell lines
following co-culture with HSPCs (G). Three independently isolated BMEC-Akt1 and BMS-Akt1 cell lines were analyzed.Klf4) and downregulated the expression of four genes
(Ackr4,Angpt1,Cxcl10, andGdf11). These data demonstrate
that reciprocal cross-talk occurs between HSPCs and the
supporting feeder cells and provide a platform to elucidate
and test paracrine factors that can modulate the mainte-
nance of repopulating HSCs ex vivo.
Transplantation of BMEC-Akt1 Promotes
Hematopoietic Regeneration
Long-term survival of many hematological diseases re-
quires radiation and/or chemotherapy to induce remission.
One underappreciated mechanism that can account for
the deleterious effects of this therapy in patients is that theStem Cell Rirreversible damage radiological or chemotherapeutic insult
may cause to the BM microenvironment. Because the
vascular niche is critical for recovery of the hematopoietic
compartment and maintain HSCs ex vivo, we tested
whether transplantation of healthy niche-specific BMEC-
Akt1 cells could improve hematopoietic recovery following
insult. C57BL/6J mice were subjected to 700 Rads of total
body irradiation (TBI), corresponding to anLD50myeloabla-
tive dose, and transplantedwith either 53 105 BMEC-Akt1,
53 105 BMS-Akt1, or PBS (control) on 4 successive days.He-
matopoietic recovery of peripheral bloodwas assessed every
7 days, and survival wasmonitored for 28 days post-irradia-
tion, atwhich timemicewere sacrificed andassayed for totaleports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 The Authors 887
Figure 6. Transplantation of BMEC-Akt1 Promotes Survival and Rapid Hematopoietic Recovery Following Myeloablation
(A) C57BL/6J mice were subjected to an LD50 dose of TBI (700 Rads), transplanted on four successive days post-irradiation with either
5 3 105 BMEC-Akt1, 5 3 105 BMS-Akt1, or PBS control and assayed for hematopoietic recovery.
(B) BMEC-Akt1, but not BMS-Akt1 transplantation, expedites peripheral hematopoietic recovery.
(C) BMEC-Akt1 transplantation, but not BMS-Akt1 or PBS controls, absolutely mitigate radiation-induced death.
(D) BMEC-Akt1 transplantations protect phenotypic LT-HSCs. LT-HSCs were quantified from WBM using LKS and CD150+CD48 markers.
(E) Hematopoietic progenitor activity in BMEC-Akt1, BMS-Akt1, and PBS transplanted mice. CFUs were assayed from CD45+ WBM at day 28
post-irradiation.
(F) H&E-stained BM (trabecular region-femur) show cytopenia 28 days post-irradiation in BMS-Akt1 and PBS control mice, while BMEC-
Akt1 transplantations display marked recovery. The spleen, including both red (asterisk) and white pulp (arrowhead), and intestine also
demonstrate preserved tissue morphology. n = 10 mice per cell transplant; n = 20 mice per PBS transplant. Error bars mean ± SEM and
significance was determined by Student’s t test; *p < 0.05, **p < 0.01, ***p < 0.001. Survival curve probability was determined using the
log-rank test.LT-HSC recovery, hematopoietic progenitor activity, and
tissue morphology (Figure 6A). Mice transplanted with
BMEC-Akt1 displayed a rapid recovery of total white blood
cells, red blood cells, and platelets in the peripheral blood,
with significant gains as early as 14-days post-irradiation
and a return to steady-state levels by day 21 (Figure 6B),
while surviving BMS-Akt1 and PBS injected mice were in
active recovery at day 28. BMEC-Akt1 cells completely
mitigated radiation-induced hematopoietic failure and
death, independent of a BM transplant, suggesting a tem-
pering of radiation-induced hematopoietic cell damage or
reestablishment of a functional BMmicroenvironment (Fig-
ure 6C). BMS-Akt1 transplantation partially mitigated radi-
ation-induced death, but was not significantly different
when compared with PBS controls. BMEC-Akt1 transplants
also demonstrated an increase in the frequency of pheno-
typic LT-HSCs (Figure 6D). While transplantation of both
BMEC-Akt1 and BMS-Akt1 maintained appreciable levels
of progenitor activity, only CFU-M and CFU-GM signifi-
cantly differed between cell types (Figure 6E). Histology of
the trabecular region of the femur BMEC-Akt1 transplanta-
tion demonstrated a striking radio-protective effect when888 Stem Cell Reports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 Thecompared to BMS-Akt1 and PBS controls, with little observ-
able BMhypocellularity associatedwithmyeloablation (Fig-
ure 6F). BMEC-Akt1 transplantation also had a profound ef-
fect on the morphology of the spleen following TBI, which
displayed normal architecture, including localized red and
white pulp (Figure 6F). BMEC-Akt1 transplants also showed
a distinct preservation of another radiosensitive tissue, the
intestine (Figure6F).Thesedatademonstrate that transplan-
tation of BMEC-Akt1, but not BMS-Akt1, results in a protec-
tive effect that mitigates deleterious consequences associ-
ated with TBI.
To examine the possibility that soluble factors produced
by BMEC-Akt1 are promoting hematopoietic recovery
following myeloablation, BMEC-Akt1 conditioned media
were administered to C57BL/6J mice following 700 Rads
of TBI, and hematopoietic recovery was monitored for
28-days post-irradiation (Figure S5A). BMEC-Akt1 trans-
planted mice displayed more efficient peripheral white
blood cell, red blood cell, and platelet recovery compared
with conditioned media (Figure S5B). While both BMEC-
Akt1 transplanted and conditionedmedia infusedmice dis-
played a reduction inmortality, BMEC-Akt1mice displayedAuthors
complete survival and conditionedmedia demonstrated an
incomplete attenuation of radiation-induced death (Fig-
ure S5C). Mice transplanted with BMEC-Akt1, but not
conditioned media, demonstrated an increase in the fre-
quency of phenotypic LT-HSCs (Figure S5D), with no
observable changes in progenitor activity (Figure S5E).
Conditioned media failed to protect radiosensitive tissues,
when compared with BMEC-Akt1 controls (Figure S5F).
BMEC-Akt1 Do Not Engraft Tissues Following
Myeloablative Transplantation
To determine whether BMEC-Akt1 radioprotection was
mediated by vascular engraftment, we examined tissues
and peripheral blood at short- and long-term time points
following an LD50 dose of TBI following transplantation
of mCherry-labeled BMEC-Akt1 (derived from CD45.2+
mice) into syngeneic CD45.1+ recipients (Figure S6A). Un-
labeled CD45.2+ WBM transplantations were used as
controls. mCherry+ BMEC-Akt1 cells were present in the
peripheral blood at days 4 and 7 post-irradiation (Fig-
ure S6B), butwere undetectable at day 14 and 16weeks (Fig-
ures S6B and S6D). The absence of detectable CD45.2+
hematopoietic cells in mCherry-BMEC-Akt1 transplanted
mice at short- and long-term time points confirms that
hematopoietic recovery is independent of contaminating
hematopoietic cells in our cultures (Figures S6C and S6D).
To assess tissue-specific BMEC-Akt1 engraftment, trans-
planted mice were intravitally labeled with Isolectin-B4
prior to sacrifice and assayed by immunohistochemistry
(IHC) at short- and long-term time points. mCherry+
BMEC-Akt1 were present within the BM at early time
points, but were absent at 16-weeks post-irradiation (Fig-
ure S6E). mCherry+ BMEC-Akt1 cells were not observed
in the spleen at either short- or long-term time points
(Figure S6F). mCherry+ BMEC-Akt1 cells were also unde-
tectable within the BM microenvironment by flow cyto-
metry at 16 weeks (data not shown). Therefore, BMEC-
Akt1 are transiently present following myeloablative
injury, but do not engraft tissues long-term, consistent
with other reports (Chute et al., 2007; Li et al., 2010;
Salter et al., 2009). These data suggest that transplanted
BMEC-Akt1 exerts its pro-regenerative effects rapidly and
transiently.
Niche-Specific ECs Promote Efficient Hematopoietic
Recovery
Each organ is endowed with specialized endothelium that
has a unique angiocrine signature that may support their
resident stem cells (Nolan et al., 2013). Tissue-specific ECs
can enhance organ regeneration, while non-resident ECs
are unable to elicit the same regenerative effect (Ding
et al., 2010, 2011). To test this, 5 3 105 niche-specific
BMEC-Akt cells or non-hematopoietic pulmonary arteryStem Cell RECs, brain microvascular ECs, or secondary-hematopoietic
BM endothelial progenitor cells (BM EPCs) were trans-
planted into C57BL/6J mice following an LD50 dose of
TBI (Figure 7A). While all EC transplants prevented radia-
tion-induced death (Figure 7C), mice transplanted with
BMEC-Akt1 displayed an accelerated recovery of white
blood cells, red blood cells, and platelets in the peripheral
blood (Figure 7B). BMEC-Akt1 transplantations demon-
strate more phenotypic LT-HSCs than lung EC and
PBS controls, but brain and BM EPC transplantations
displayed higher phenotypic LT-HSCs when compared
with BMEC-Akt1 (Figure 7D). However, representative
LKS CD150+CD48 contour plots demonstrate that
BMEC-Akt1 LT-HSCs are comparable to steady-state con-
trols, while lung EC, brain EC, and BM EPC appeared to
be in active recovery (Figure S7). While all EC transplants
maintained progenitor activity following TBI, BMEC-Akt1
demonstrated the highest activity in CFU-GEMMs when
compared with EC controls (Figure 7E). BMEC-Akt1 trans-
plants also displayed improved radioprotection of the
BM, spleen, and intestine when compared with EC and
EPC controls (Figure 7F).DISCUSSION
At present, it is unclear whether BMECs serve as the pri-
mary HSC niche that provides the necessary cues for main-
tenance of LT- HSCs in the adult BM. Recent evidence has
demonstrated that EC-specific deletion of Kitl and Cxcl12
results in a depletion ofHSCs at steady state (Ding andMor-
rison, 2013; Ding et al., 2012; Greenbaum et al., 2013),
while ablation of perivascular BM cells also results in signif-
icant HSC defects (Kunisaki et al., 2013; Zhou et al., 2014).
However, these studies have not fully addressed the effects
that cellular ablation or genetic modulation of target BM
niche cells have on neighboring BM niche constituents,
allowing for the possibility that reported HSC defects are
indirectly due to dysfunction in untargeted niche cells.
Given these limitations, we aimed to isolate BMECs and
BMS cells from the BMmicroenvironment to explore their
role in supporting HSC function, independent of other
candidate BM niche cells (Calvi et al., 2003; Ding et al.,
2012; Katayama et al., 2006; Kunisaki et al., 2013; Me´n-
dez-Ferrer et al., 2008, 2010; Omatsu et al., 2010; Yamazaki
et al., 2011). We describe the isolation of BM-derived ECs
and stroma that maintain their gene expression profiles
and functional characteristics following AKT1 activation.
The derivation of stable and robust primary murine
BMEC-Akt1 and BMS-Akt1 cultures allowed us to interro-
gate their instructive functions in maintaining bona
fide HSCs ex vivo, independent of exogenous serum and
complex cytokine cocktails. Utilizing this system, weeports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 The Authors 889
Figure 7. Niche-Specific ECs Efficiently Promote Hematopoietic Recovery Following Myeloablation
(A) C57BL/6J mice were subjected to an LD50 dose of TBI (700 Rads), transplanted on four successive days post-irradiation with either
5 3 105 BMEC-Akt1, 5 3 105 pulmonary artery ECs, 5 3 105 brain microvascular ECs, 5 3 105 BM EPCs, or PBS control and assayed for
hematopoietic recovery.
(B) Transplantation of niche-specific BMEC-Akt1 more efficiently promotes peripheral hematopoietic recovery when compared with
heterogeneous EC populations.
(C) EC transplantation mitigates radiation-induced death. All heterogeneous ECs tested promote survival following irradiation.
(D) Quantification of phenotypic LT-HSCs 28-days post-EC transplantation. LT-HSCs were quantified fromWBM using LKS and CD150+CD48
markers.
(E) Hematopoietic progenitor activity in EC transplanted mice. CFUs were assayed from CD45+ WBM at day 28 post-irradiation.
(F) H&E-stained BM (trabecular region-femur) show cytopenia 28-days post-irradiation in EC and PBS control mice, while BMEC-Akt1
transplantations display pronounced recovery. The spleen, including both red (asterisk) and white pulp (arrowhead), and intestine also
demonstrate preserved tissue morphology. n = 10 mice per cell transplant; n = 20 mice per PBS transplant. Error bars represent mean ± SEM,
and significance was determined by Student’s t test; *p < 0.05, **p < 0.01, ***p < 0.001. Survival curve probability was determined using
the log-rank test.demonstrate that BMEC-Akt1 cultures, but not BMS-Akt1,
are capable of supporting ex vivo cultures of LT-HSCs that
achieve long-term, multilineage engraftment. While the
addition of exogenous sKITL in BMEC-Akt1 co-cultures890 Stem Cell Reports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 Theenhanced HSC engraftment, HSCs are also maintained in
the absence of sKITL, suggesting that BMEC-Akt1 alone
can provide sufficient cues to support repopulating HSCs
ex vivo.Authors
Given the mounting data demonstrating that HSCs
reside in close proximity to the BM vascular niche, we set
out to explore mechanisms that govern HSC maintenance
in culture with BMEC-Akt1 and BMS-Akt1 cells. Using
our co-culture system, we analyzed the differential gene
expression in BMEC-Akt1 and BMS-Akt1 cells following
HSPC co-culture. BMEC-Akt1 and BMS-Akt1 cells demon-
strated only minor changes in known pro-HSC growth
factors; however, differentially expressed chemokine/
cytokine and transcription factor profiles in both BMEC-
Akt1 and BMS-Akt1 cells suggest yet unappreciated recip-
rocal mechanisms that support HSC function. Because
BMEC-Akt1, but not BMS-Akt1, were able to support
bona fide LT-HSCs ex vivo, the described co-culture sys-
tem can serve as a platform to identify and test growth
factors that modulate LT-HSC quiescence, self-renewal,
and proliferation, providing critical knowledge for the
development of HSPC therapeutic applications. To further
understand the intimate cross-talk between HSCs and
their representative niche cells, additional transcriptional
analysis of co-cultured hematopoietic cells is needed to
establish a comprehensive framework outlining candidate
niche-HSC interactions.
BMniche constituents, including BMECs, are susceptible
to ionizing radiation and undergo non-apoptotic cell death
in response to insult (Hooper et al., 2009; Kunisaki et al.,
2013; Li et al., 2008). Following radiation-induced injury
of BM sinusoids, HSCs relocate to the arteriole-rich endos-
teum vascular niche (Lo Celso et al., 2009; Xie et al., 2009).
While relocation of HSCs may occur because the arte-
riole vascular niche is more resistant to irradiation than
sinusoidal ECs, it raises the possibility that the arteriole
vasculature is capable of supporting active HSPC prolifera-
tion and self-renewal, promoting hematopoietic recovery
following myeloablation. This led us to examine whether
BMEC-Akt1 could be used as a cellular therapy to treat he-
matological disorders in vivo. Using a modified transplan-
tation protocol (Chute et al., 2007; Li et al., 2010; Salter
et al., 2009), we injected BMEC-Akt1 cells following an
LD50 dose of ionizing radiation and assessed recovery of
the hematopoietic system. Cultured BMEC-Akt1 cells pro-
moted rapid hematopoietic recovery of leukocytes, plate-
lets, and red blood cells, with a distinct radio-protective
effect on the BM HSPC compartment. Transplantation
also completely mitigated radiation-induced death, while
protecting the integrity of other radiosensitive tissues.
Mice transplanted with BMS-Akt1 cells displayed a moder-
ate attenuation of radiation-induced death, but did not
achieve significant enhancement in hematopoietic recov-
ery or mitigate the damage to radiosensitive tissue. Because
the radio-protective effects of BMEC-Akt1 transplantations
are independent of in vivo engraftment, the question re-
mains as to how these cells transiently elicit their pro-Stem Cell RHSPC response following myeloablation. To determine
whether angiocrine factors secreted by BMEC-Akt1 cultures
could enhance hematopoietic recovery following irradia-
tion, we infused BMEC-Akt1-conditioned media. While
conditioned media promote an intermediate increase in
survival, they did not enhance peripheral hematopoietic
recovery. The delay in hematopoietic recovery in condi-
tioned media cohorts demonstrates that soluble factors
can partially support survival, suggesting that membrane-
bound factors or other cellular constituents are also im-
portant for endothelial-mediated radioprotection. Radio-
protection of multiple tissues suggests a comprehensive
safeguard of tissue-specific niches and resident stem
cells, allowing for native regeneration following a global
insult. These data provide evidence that transplantation
of BMEC-Akt1 cells modulate HSPCs in vivo, promoting
efficient and rapid recovery of hematopoiesis following
injury. The ability to culture long-term ECs and transplant
them following injury provides a unique experimental
platform to test specific factors/mechanisms within endo-
thelium that promote rapid tissue regeneration.
Previous studies have demonstrated that transplantation
of allogeneic or syngeneic endothelium isolated from non-
hematopoietic tissues enhance hematopoiesis following
myelosuppression (Chute et al., 2007; Li et al., 2010;
Montfort et al., 2002; Salter et al., 2009). We set out
to test whether niche-specific BMEC-Akt1 cells would
preferentially promote hematopoietic recovery following
myeloablation. Compared with non-hematopoietic and
secondary hematopoietic EC sources, BMEC-Akt1 was su-
perior at promoting hematopoietic recovery following
TBI and elicited a significant multiorgan radio-protective
effect. These data suggest that organ-specific endothelium
are more efficient in supporting the maintenance and
regeneration of their tissue-resident stem cells.
It is plausible that the heterogeneous function of the
vascular niche (Ding and Morrison, 2013; Ding et al.,
2012; Kunisaki et al., 2013) is defined by the complex inter-
actions between all candidate niche cells within the BM
microenvironment. It is not entirely surprising that uncou-
pling BMECs from perivascular niche cells would allow
for the maintenance of HSCs, but also require partial
supplementation with sKITL. Moreover, BMS-Akt1 cells
that retain MSC properties, but cannot support HSPCs
ex vivo, do not rule out the possibility that the endothe-
lial-perivascular ‘‘compound niche’’ is required for the
maintenance of the HSC in vivo. The development of
ex vivo systems that allow for the co-culture of BM niche
cells is needed to elucidate cell-specific and compound
niche support of HSPCs. These robust vascular and stromal
platforms can also be used to examine the functional ca-
pacity of any candidate factors of interest. The described
co-culture/transplantation system is not limited to HSPCs,eports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 The Authors 891
but can be a potentially useful platform for many tissue-
specific stem cell-niche interactions.
Taken together, we have uncovered a therapeutic appli-
cation for the transplantation of niche-specific BMEC-
Akt1 cells following myeloablative treatment. Therapeutic
transplantation of BM endothelium, with the infusion of
newly discovered pro-HSPCs factors, may create a permis-
sive microenvironment that promotes an increase in the
number of engrafted HSPCs following BM transplantation,
accelerating the rate of hematopoietic recovery following
radiation or chemotherapeutic regimens and decreasing
the morbidity and mortality associated with life-threat-
ening pancytopenias.EXPERIMENTAL PROCEDURES
Animals
Animal procedures were done in accordance with Weill Cornell
Medical College and Institutional Animal Care and Use Commit-
tee guidelines. C57BL/6J (CD45.2) and B6.SJL-Ptprca Pepcb/BoyJ
(CD45.1) mice were obtained from Jackson Labs. Vegfr3::YFP
mice were obtained from Jean-Leon Thomas (Calvo et al., 2011)
at Yale University.
BM Endothelial and Stromal Cell Culture
BMECs were immunopurified using CD31-captured (Biolegend)
magnetic beads (Life Technologies) from digested and lineage
depleted (Miltenyi Biotec) adult (12 week) C57BL/6J WBM. BMS
were obtained from the CD31 fraction. Resulting BMEC and
BMS cultures were transduced with a myristoylated-Akt1 express-
ing lentivirus (Kobayashi et al., 2010) and cultured on fibro-
nectin-coated plates (Sigma-Aldrich).
Ex Vivo Hematopoietic Co-cultures
CD45.2+ LKS HSPCs were plated in StemSpan SFEM (StemCell
Technologies) serum-free media on BMEC-Akt1/BMS-Akt1/no
feeders with 50-ng/ml sKITL and cultured for 9 days. Co-cultures
were supplemented with StemSpan SFEM and sKITL every 2 days
and split to adjacent wells as needed. Phenotypic HSPC numbers
were determined by CD45+ LKS quantification. To assess LT-HSC
engraftment, total CD45.2+ co-cultured cells were transplanted
with CD45.1+ WBM into lethally irradiated CD45.1 recipients.
For secondary transplantation, WBM from primary engrafted
mice was transplanted into lethally irradiated CD45.1+ recipients.
Multilineage engraftment was determined by flow cytometry of
peripheral blood.
BM Endothelial and Stromal Transplantation
Syngeneic BMEC-Akt1 and BMS-Akt1 cells were transplanted on
four successive days (via retro-orbital injection) following an
LD50 dose of TBI as previously described (Chute et al., 2007; Salter
et al., 2009). C57BL/6J BMEC-Akt1 and BMS-Akt1 cells were iso-
lated and cultured as described above. Primary C57BL/6 brain
microvascular ECs, pulmonary artery ECs, and BM EPCs were ob-
tained from Cell Biologics and cultured according to the manufac-892 Stem Cell Reports j Vol. 5 j 881–894 j November 10, 2015 j ª2015 Theturer’s suggestions. Hematopoietic recovery was monitored using
an Adiva120 (Bayer Healthcare). LT-HSC frequency from WBM
was determined by flow cytometry and was defined as LKS and
CD150+CD48.
Colony Assay
Hematopoietic progenitor activity was determined by quantifying
CFUs in semisolid methylcellulose (StemCell Technologies) ac-
cording to the manufacturer’s protocol.
Matrigel
BMEC-Akt1 and BMS-Akt1 cells, transduced with mCherry and
mCerulean expressing lentivirus, respectively (Papapetrou et al.,
2009), were mixed with Matrigel (Corning) and injected subcuta-
neously into adult (12 week) C57BL/6J mice. Anastomosis was as-
sessed after 14 days by intravital staining of the vasculature via
retro-orbital injection of 25 mg of fluorescently conjugated VECAD
antibody.
Stromal Differentiation
Subconfluent BMS-Akt1 were cultured in Osteogenic (StemCell
Technologies), Adipogenic (StemCell Technologies), or Chondro-
genic (Life Technologies) differentiationmedia for 14 days. Result-
ing differentiations were stained with Alizarin Red S, Oil Red O,
and Toluidine Blue O or processed with Trizol (Life Technologies)
according to the manufacturer’s protocol. Differentiations were
imaged on an Evos XL (AMG).
RNA Analysis
BMEC-Akt1 and BMS-Akt1 cells were processed using Trizol (Life
Technologies) according to the manufacturer’s protocol. Co-
cultured feeders (CD45) were sorted into Trizol LS (Life Technol-
ogies) and processed according to the manufacturer’s instructions.
RNA libraries were prepared and sequenced using the TruSeq kit (Il-
lumina) and sequenced on a HiSeq2000 (Illumina). qRT-PCR was
performed using Superscript III (Life Technologies)-generated
cDNA and SYBR Green (Applied Biosystems) with gene-specific
primers according to the manufacturer’s suggestions.
Histology and Immunhistochemistry
H&E staining of 12-mm paraffin sections was performed by Histo-
serv and imaged on a BX51 (Olympus) light microscope. Veg-
fr3::YFPmice were intravitally labeled with a fluorescently labeled
VECAD antibody. Femurs were fixed in 4% paraformaldehyde
(PFA), decalcified in 10% EDTA, and embedded in O.C.T. (VWR);
12 mm cryosections were post-stained with a SCA1 antibody.
Cultured BMEC-Akt1 and BMS-Akt1 cells were fixed in 4% PFA
and post-stained with antibodies as previously described (Butler
et al., 2010; Poulos et al., 2013). Sections were counterstained
with DAPI (Biolegend) and imaged on a LSM 710 confocal micro-
scope (Zeiss).
Statistics
Survival curve significance was calculated using the log-rank test.
Statistical significance was determined using Student’s t test, and
values are represented as SEM.Authors
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